Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data

Dongyu Zhang, Shailesh Advani, Megan Huchko, Dejana Braithwaite, Dongyu Zhang, Shailesh Advani, Megan Huchko, Dejana Braithwaite

Abstract

Objective: Previous studies identified several factors associated with cervical cancer screening. However, many of them used samples from the general population and limited studies focused on women with high-risk health behaviours. We aimed to disentangle the association of cervical cancer screening with healthcare access and HIV testing among women at a high risk of HIV infection.

Design: Nationwide cross-sectional survey in the USA.

Setting: 2016 Behavioral Risk Factor Surveillance System.

Participants: 3448 women with a history of high-risk behaviours associated with HIV infection EXPOSURE AND OUTCOME: Clinical check-up, having personal healthcare provider, health coverage and HIV testing history were treated as exposures. Appropriate cervical cancer screening, which was defined according to 2016 US Preventive Services Task Force guideline, was treated as the outcome of interest.

Data analysis: Multivariable logistic regression model was performed to evaluate associations of healthcare access and HIV testing with the uptake of cervical cancer screening; adjusted odds ratio (aOR) and 95% CI were reported. We further investigated if educational attainment modified associations identified in the primary multivariable model.

Results: A total of 2911 (84.4%) high-risk women in our sample underwent cervical cancer screening. In the multivariable model, delayed clinical check-up (≥5 years ago vs within the past year: aOR: 0.19, 95% CI: 0.14 to 0.26), having no health insurance (aOR: 0.60, 95% CI: 0.46 to 0.79) and no history of HIV testing (no testing vs testing within the past year: aOR: 0.46, 95% CI: 0.35 to 0.61) were inversely associated with cervical cancer screening utilisation.

Conclusion: Factors reflecting healthcare access, specifically clinical check-up and health coverage, as well as history of HIV testing were associated with cervical cancer screening in this population-based study of high-risk women. Targeted interventions are warranted to further increase cervical cancer screening among women at high risk of HIV infection.

Keywords: cancer screening; cervical cancer; epidemiology.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Flowchart of selection of study population. A total of 3448 women at a high risk of HIV infection were included for current study. BRFSS, Behavioral Risk Factor Surveillance System.

References

    1. Cancer STAT facts: cervical cancer. Available: [Accessed Last accessed 27th Oct 2018].
    1. Brown AJ, Trimble CL. New technologies for cervical cancer screening. Best Pract Res Clin Obstet Gynaecol 2012;26:233–42. 10.1016/j.bpobgyn.2011.11.001
    1. Devesa SS, Young JL, Brinton LA, et al. . Recent trends in cervix uteri cancer. Cancer 1989;64:2184–90. 10.1002/1097-0142(19891115)64:10<2184::AID-CNCR2820641034>;2-8
    1. Zhang D, Sun X. Pap testing in the USA and potential association with HPV vaccination: a cross-sectional analysis of the BRFSS data (2007–2016). J Gen Intern Med 2019;34:17–19. 10.1007/s11606-018-4652-y
    1. Selvin E, Brett KM. Breast and cervical cancer screening: sociodemographic predictors among white, black, and Hispanic women. Am J Public Health 2003;93:618–23. 10.2105/AJPH.93.4.618
    1. Austin LT, Ahmad F, McNally M-J, et al. . Breast and cervical cancer screening in Hispanic women: a literature review using the health belief model. Women's Health Issues 2002;12:122–8. 10.1016/S1049-3867(02)00132-9
    1. Kaso M, Takahashi Y, Nakayama T. Factors related to cervical cancer screening among women of childrearing age: a cross-sectional study of a nationally representative sample in Japan. Int J Clin Oncol 2019;24:313-322 10.1007/s10147-018-1350-z
    1. Zhao G, Okoro CA, Li J, et al. . Health insurance status and clinical cancer screenings among U.S. adults. Am J Prev Med 2018;54:e11–19. 10.1016/j.amepre.2017.08.024
    1. Rodríguez MA, Ward LM, Pérez-Stable EJ. Breast and cervical cancer screening: impact of health insurance status, ethnicity, and nativity of Latinas. Ann Fam Med 2005;3:235–41. 10.1370/afm.291
    1. Injection drug use and HIV risk. Available: [Accessed Last accessed 28th Oct 2018].
    1. Paz-Bailey G, Noble M, Salo K, et al. . Prevalence of HIV among U.S. female sex workers: systematic review and meta-analysis. AIDS Behav 2016;20:2318–31. 10.1007/s10461-016-1332-y
    1. Jia H, Wang X, Long Z, et al. . Human papillomavirus infection and cervical dysplasia in female sex workers in northeast China: an observational study. BMC Public Health 2015;15:695 10.1186/s12889-015-2066-x
    1. Abraham AG, D'Souza G, Jing Y, et al. . Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr 2013;62:405–13. 10.1097/QAI.0b013e31828177d7
    1. Ferenczy A, Coutlée F, Franco E, et al. . Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ 2003;169:431–4.
    1. Cerigo H, Coutlée F, Franco EL, et al. . Factors associated with cervical cancer screening uptake among Inuit women in Nunavik, Quebec, Canada. BMC Public Health 2013;13:438 10.1186/1471-2458-13-438
    1. Ncube B, Bey A, Knight J, et al. . Factors associated with the uptake of cervical cancer screening among women in Portland, Jamaica. N Am J Med Sci 2015;7:104–13. 10.4103/1947-2714.153922
    1. Centers for Disease Control and Prevention (CDC) Behavioral risk factor surveillance system survey questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2018.
    1. Centers for Disease Control and Prevention (CDC) Behavioral risk factor surveillance system survey data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2018.
    1. HIV testing. Available: [Accessed Last accessed 25th Jan 2019].
    1. Sabatino SA, White MC, Thompson TD, et al. . Cancer screening test use - United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:464–8.
    1. Van Jaarsveld CHM, Miles A, Edwards R, et al. . Marriage and cancer prevention: does marital status and inviting both spouses together influence colorectal cancer screening participation? J Med Screen 2006;13:172–6. 10.1177/096914130601300403
    1. Miles-Richardson S, Allen S, Claridy MD, et al. . Factors associated with self-reported cervical cancer screening among women aged 18 years and older in the United States. J Community Health 2017;42:72–7. 10.1007/s10900-016-0231-5
    1. Richard A, Rohrmann S, Schmid SM, et al. . Lifestyle and health-related predictors of cervical cancer screening attendance in a Swiss population-based study. Cancer Epidemiol 2015;39:870–6. 10.1016/j.canep.2015.09.009
    1. Zhang D, Zhang C, Sun X, et al. . Bmi, physical inactivity, and Pap test use in Asian women in the U.S. Am J Prev Med 2019;56:e85–94.
    1. Fleming MF. Screening and brief intervention in primary care settings. Alcohol Res Health 2004;28:57–62.
    1. Kiefe CI, Funkhouser E, Fouad MN, et al. . Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 1998;13:357–65. 10.1046/j.1525-1497.1998.00115.x
    1. Bazargan M, Bazargan SH, Farooq M, et al. . Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med 2004;39:465–73. 10.1016/j.ypmed.2004.05.003
    1. Shaikh BT. Understanding social determinants of health seeking behaviours, providing a rational framework for health policy and systems development. J Pak Med Assoc 2008;58:33–6.
    1. Zhang Q, Lauderdale D, Mou S, et al. . Socioeconomic disparity in healthcare-seeking behavior among Chinese women with genitourinary symptoms. J Womens Health 2009;18:1833–9. 10.1089/jwh.2009.1394
    1. Barnes A, Betts AC, Borton EK, et al. . Cervical cancer screening among HIV-infected women in an urban, United States safety-net healthcare system. AIDS 2018;32:1861–70. 10.1097/QAD.0000000000001881
    1. McKnight B, McKnight I, Kerr T, et al. . Prevalence and correlates of cervical cancer screening among injection drug users. J Obstet Gynaecol Can 2006;28:695–9. 10.1016/S1701-2163(16)32237-X
    1. Duff P, Ogilvie G, Shoveller J, et al. . Barriers to cervical screening among sex workers in Vancouver. Am J Public Health 2016;106:366–73. 10.2105/AJPH.2015.302863
    1. Maruthur NM, Bolen SD, Brancati FL, et al. . The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity 2009;17:375–81. 10.1038/oby.2008.480
    1. Taylor VM, Yasui Y, Burke N, et al. . Pap testing adherence among Vietnamese American women. Cancer Epidemiol Biomarkers Prev 2004;13:613–9.
    1. Jennings-Dozier K. Predicting intentions to obtain a Pap smear among African American and Latina women: testing the theory of planned behavior. Nurs Res 1999;48:198–205. 10.1097/00006199-199907000-00002
    1. Nguyen TT, McPhee SJ, Nguyen T, et al. . Predictors of cervical Pap smear screening awareness, intention, and receipt among Vietnamese-American women. Am J Prev Med 2002;23:207–14. 10.1016/S0749-3797(02)00499-3
    1. Ford ME, Vernon SW, Havstad SL, et al. . Factors influencing behavioral intention regarding prostate cancer screening among older African-American men. J Natl Med Assoc 2006;98:505–14.
    1. Anderson M, Dobkin C, Gross T. The effect of health insurance coverage on the use of medical services. Am Econ J Econ Policy 2012;4:1–27. 10.1257/pol.4.1.1
    1. Ghebre RG, Grover S, Xu MJ, et al. . Cervical cancer control in HIV-infected women: past, present and future. Gynecol Oncol Rep 2017;21:101–8. 10.1016/j.gore.2017.07.009
    1. Ortiz AP, Engels EA, Nogueras-González GM, et al. . Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States. Cancer 2018;124:4520–8. 10.1002/cncr.31702

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren